Mesa Biotech's Accula RSV Test Receives FDA's 510(K) Clearance and CLIA Waiver for Respiratory Infections
Shots:
- Accula RSV is second POC (point-of-care) test- to receive FDA’s 510(K) & CLIA Waiver and used additionally with nasal swab collection with disposable test cassettes
- The Accula RSV (respiratory syncytial virus) test is performed for detection of respiratory tract infections like bronchiolitis & pneumonia in adults and children
- In 2017- Sekisui Diagnostics collaborated with Mesa Biotech for commercialization of Accula RSV test as Silaris in the US and Canada
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
